Skip to main content

Table 1 Patient, donor, and transplant characteristics

From: Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia

 

G-BM (n = 49)

G-PBSC (n = 52)

P value

Patient age, median(range), year

30(13–59)

33(16–48)

NS

Male patients (%)

24(48.9)

28(53.8)

NS

Underlying diseases (%)

 AML

34(69.4)

34(65.4)

NS

 ALL

15 (30.6)

18(34.6)

NS

Risk classification (%)

 Standard risk

26(53.1)

27(51.9)

NS

 High risk

23(46.9)

25(48.1)

NS

Donor age, median(range), year

34(10–20)

38(17–55)

NS

Male donors (%)

25(51.0)

28(53.8)

NS

Female to male (%)

16(32.6)

18(34.6)

NS

Median TNC, 108/kg (range)

5.8(3.8–8.2)

8.7(7.2–12.5)

P < 0.01

Median CD34+ cell count, 106/kg (range)

3.6(2.3–10.0)

5.6(3.5–12.3)

P < 0.01

Median CD3+ cell count, 106/kg (range)

69.6(22–156)

285.8(68–467)

P < 0.01

  1. ALL acute lymphoblastic leukemia, AML acute myelogenous leukemia, TNC total nucleated cells